Patents by Inventor Kenneth Eli Morgenstern

Kenneth Eli Morgenstern has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20240108574
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: December 1, 2023
    Publication date: April 4, 2024
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 11865209
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: April 1, 2019
    Date of Patent: January 9, 2024
    Assignee: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20190224113
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: April 1, 2019
    Publication date: July 25, 2019
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 10245226
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: March 19, 2018
    Date of Patent: April 2, 2019
    Assignee: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20180207092
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: March 19, 2018
    Publication date: July 26, 2018
    Applicant: KEM PATENT HOLDINGS, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 9962332
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: April 14, 2016
    Date of Patent: May 8, 2018
    Assignee: KEM Patent Holdings, LLC
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 9452133
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer which comprises administering to the eyes of said patient an effective amount of perchlorate anion.
    Type: Grant
    Filed: April 25, 2005
    Date of Patent: September 27, 2016
    Assignee: KEM Patent Holdings, LLC
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20160220605
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: April 14, 2016
    Publication date: August 4, 2016
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 9314426
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: March 25, 2014
    Date of Patent: April 19, 2016
    Assignee: KEM HOLDINGS
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20140205683
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: March 25, 2014
    Publication date: July 24, 2014
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 8722012
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: August 8, 2013
    Date of Patent: May 13, 2014
    Inventor: Kenneth Eli Morgenstern
  • METHOD FOR PREVENTING NASOLACRIMAL DUCT OBSTRUCTION
    Publication number: 20130323327
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Application
    Filed: August 8, 2013
    Publication date: December 5, 2013
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Patent number: 8529871
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer. The method includes administering an effective amount of perchlorate anion to the eyes of the patient.
    Type: Grant
    Filed: February 4, 2008
    Date of Patent: September 10, 2013
    Inventor: Kenneth Eli Morgenstern
  • Method for preventing nasolacrimal duct obstruction
    Publication number: 20080124271
    Abstract: The invention is directed to a method for preventing nasolacrimal duct obstruction (NLDO) in a patient receiving high dose radioactive iodine for treatment of cancer which comprises administering to the eyes of said patient an effective amount of perchlorate anion.
    Type: Application
    Filed: February 4, 2008
    Publication date: May 29, 2008
    Inventor: Kenneth Eli Morgenstern